# Efficacy of Carminal in Helicobacter Pylori Gastritis

> **NCT07179237** · PHASE2 · RECRUITING · sponsor: **Catalysis SL** · enrollment: 80 (estimated)

## Conditions studied

- H Pylori Gastritis
- H Pylori Infection
- H Pylori Eradication
- Gastritis Associated With Helicobacter Pylori
- Gastric Mucosal Lesion

## Interventions

- **DIETARY_SUPPLEMENT:** Carminal Oral solution
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07179237
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-04
- **Primary completion:** 2026-08-03
- **Final completion:** 2026-10-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07179237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07179237, "Efficacy of Carminal in Helicobacter Pylori Gastritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07179237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*